- Overcoming difficulties of low-expressing proteins in typical ​​in fed-batch processes
- Enabling previously cost-prohibitive projects to enter clinical trials by establishing a cost-effective production path
- Bringing your difficult-to-express protein through clinical trials quickly, safely, and cost-effectively using ​an ​innovative, perfusion GMP platform